PDo we unnecessarily rescribe drugs to people with dementia? According to a study by the Christian Mutualite conducted with more than 100,000 members concerned, anti-Alzheimer drugs are not effective enough. "Their usefulness is not proven and their undesirable effects are important," says Jean Hermesse, general secretary of the Christian Mutual.
A lack of efficiency also pinned by the Belgian Center for Pharmacotherapeutic Information (CBIP), a non-profit organization independent of the lobbies of the sector, which is very cautious about these drugs. The CBIP draws an unflattering list: no preventive effect on the development of the disease, few improvements in the quality of life of patients and their entourage, controversial drug associations …
However, their use has a cost for Inami: about five million euros per year, according to the Christian Mutuality which pleads to partially end this refund – while allowing current users to continue to benefit. "Our mutuality has also initiated a procedure to this effect with the Drug Reimbursement Commission (CRM)," says Jean Hermesse.
► The explanations of the Christian Mutuality, which pleads for the partial end of the reimbursement of these drugs on Le Soir +